Sub‐Tenon depository triamcinolone and glycaemic management in diabetic patients

Sub-Tenon triamcinolone acetonide (TA) is an effective anti-inflammatory treatment modality for various macular oedemas; however, the steroid-associated systemic side-effects are of concern for physicians and patients, especially for patients with diabetes. It is reported that a traditional sub-Tenon TA injection of 40 mg in 1 ml can lead to a plasma peak TA concentration of 35 ng/ml (Kovacs et al. 2012) to 72 ng/ml (Zaka-Ur-Rab et al. 2009),...